Form 4: Itron Director Sheri Savage Receives Equity Grant

Itron Director Sheri Savage was granted 529 shares of common stock as part of her quarterly board compensation, increasing her total beneficial ownership to 1,160 shares.

Summary

• Sheri Savage, a Director of Itron, Inc. (ITRI), acquired 529 shares of common stock.
• The transaction occurred on January 2, 2026, and represents a grant of shares.
• This grant is part of the quarterly compensation independent members of Itron's board of directors receive for their service.
• The acquisition price per share was $0, indicating the shares were granted, not purchased.
• Following this transaction, Ms. Savage's total beneficial ownership of Itron common stock increased to 1,160 shares.

Sentiment

Score: 7

Explanation: The grant of common stock to a director as part of routine compensation is a positive sign of alignment between management and shareholder interests, reflecting standard corporate governance practices. It does not indicate any negative operational or financial issues.

Positives

• Director Sheri Savage received 529 shares of common stock, further aligning her interests with those of shareholders.
• The grant is part of a regular, established compensation structure for independent board members, reflecting stable corporate governance practices.

Future Outlook

NA

Industry Context

This Form 4 filing details a routine insider transaction, specifically an equity grant to a director, which is a common practice in publicly traded companies to align management and board interests with shareholder value. It does not provide information on broader industry trends or competitive landscape.

Corporate Governance

Related Party Transactions

• Grant of 529 shares of common stock to Director Sheri Savage as part of her board compensation, a transaction between the company and a related party (director).

Stakeholder Impact

• Shareholders: Increased alignment of director interests with shareholder value through equity ownership.
• Employees: No direct impact mentioned in this filing.
• Customers: No direct impact mentioned in this filing.
• Suppliers: No direct impact mentioned in this filing.
• Creditors: No direct impact mentioned in this filing.

Key Dates

Recommendation

This filing details a routine equity grant to a director as part of their compensation. While positive for aligning interests, it does not present new fundamental information that would warrant a change in investment recommendation. It reinforces a 'hold' stance, indicating stable governance and compensation practices without altering the company's underlying financial or operational outlook.

Keywords

Itron, ITRI, Form 4, insider transaction, director compensation, equity grant, common stock